Results 291 to 300 of about 54,977 (304)

Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival

Pancreatology, 2014
Tianjiao Li, Chen Liu, Xianjun Yu
exaly  

The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics

Biochimica Et Biophysica Acta: Reviews on Cancer, 2023
exaly  

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

Ca-A Cancer Journal for Clinicians
Alessandro Mannucci, Ajay Goel
exaly  

Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC

Cancers
Vignesh Vudatha, Leonor G Cedillo
exaly  

PDAC TREATMENT REGIMEN

2021
WINDING BENT, KAISER CHRISTINA, HULEDAL GUNILLA   +2 more
openaire   +2 more sources

TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770–5p axis in PDAC

Drug Resistance Updates
Chunhui Cui, Yingfang Fan, Wenjie Huang   +2 more
exaly  

Four-pronged attack on PDAC

Nature Reviews Cancer
openaire   +2 more sources

Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN

Experimental Cell Research, 2017
Weiming Hu, Xubao Liu, Junjie Xiong
exaly  

CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy

International Journal of Molecular Sciences
Keishi Yamashita
exaly  

Unraveling the clinical impact of differential DNA methylation in PDAC: A systematic review

European Journal of Cancer
J Bart Rose, Changde Cheng, Smita Bhatia   +2 more
exaly